The frequency of innovations and research in the pharmaceutical industry is at an all-time high especially boosted by the pandemic. The all-in-one software solution from Veeva Systems is supporting companies, irrespective of their size, to deliver their products efficiently while maintaining compliance with regulations. Drug developers, for example, have a streamlined process from research to commercialization with the integration of Veeva.
Veeva is expanding its suite of applications to support the various needs of businesses. The company’s first purpose-built AI application, Veeva Andi, provides pharmaceutical representatives with customer insights and recommendations that can improve sales effectiveness. When combined with Veeva CRM Approved Notes, the AI technology can reduce compliance risk as well.
To put the spotlight on such key developments in the industry, this edition of Pharma Tech Outlook illustrates how companies are leveraging Veeva’s latest tools to augment pharmaceutical operations and meet the expectations of businesses. The edition features thought leadership articles from Cathlin Shapiro, Parexel, Director, Technology Quality Assurance, who sheds light on the new draft guidelines by the EMA that managers should be aware of, and Matt Southwick, Executive Director Clinical Systems and Analytical Reporting, Amgen who speaks about the implementation of analytics in clinical research.
In this edition of Pharma Tech Outlook, we also present to you some of the Veeva solution providers who offer the best outcomes for their clients. This includes SVA Consulting, a company that helps biopharmaceutical industries plan, execute and launch their innovations and products.
We hope this edition assists you in finding the most appropriate Veeva solution provider that will help you streamline your pharmaceutical business and accelerate growth.
Let us know your thoughts!
